Chiral γ-aminobutyric acid (GABA) derivatives are the normal inhibitory neurotransmitters in the mammalian central nervous system. In this paper, enantiopure GABA derivatives 6 were synthesized via reduction/cyclization/hydrolysis cascade reactions from the highly enantioselective β-aryl-γ-nitroalkanes Michael adducts 4, which was obtained from asymmetric Michael addition of S, S'-diphenyldithiomalonate 2 to trans-β-nitroolefins 1, using novel chiral cinchona alkaloid-derived thioureas 3 as the organocatalysts.
Introduction
GABA is the most common inhibitory neurotransmitters in the mammalian central nervous system (CNS) where it exerts its effects through inhibiting GABA receptors channels. And decreased GABA biological activity results in the excessive excitement of CNS (namely Neuronal Firing). The dysfunction of the [2] and other psychiatric disorders, such as anxiety and pain [3] . Various GABA derivatives and analogs are widely recognized as CNS depressants, for example: Phenibut, Baclofen (Lioresal and Baclon®), Vigabatrin, Gabapentin (GBP, Neurontin), Pregabalin (Lyrica, Pfizer's blockbuster drug, β-i-Bu-GABA) ( Figure 1 ).
Enantiomers of a drug are often known to play an important role in pharmacological actions, pharmacokinetics, toxicities and metabolism. The biological activity of some drugs depends on their absolute configuration. Therefore, the use of a single isomer of a given drug is usually recommended for clinical use [4] . It has reported that (R)-enantiomer of GABA derivatives is much more active than (S)-enantiomer [5] [6] [7] . For example, in pharmacological tests of locomotor activity, antidepressant and pain effects, (S)-phenibut was inactive in doses up to 500 mg/kg, but in contrast, (R)-phenibut turned out to be two times more potent than racemic phenibut in most of the tests. In the forced swimming test, at a dose of 100 mg/kg only (R)-phenibut significantly decreased immobility time. Consequently, obtaining enantiomerically pure GABA derivatives as a new modulators has become one of the most effective approaches for the development of extracellular GABA homeostasis in the CNS.
In this paper, we report the asymmetric Michael addition of S, S'-diphenyldithiomalonate 2 to trans-β-nitroolefins 1, catalyzed by chiral cinchona alkaloid-derived thioureas organocatalysts 3, to give a series of corresponding chiral β-aryl-γ-nitroalkanes 4 in moderate to good yields, along with excellent stereoselectivities. And their transformations into biologically attractive chiral GABA derivatives 6 via reduction/cyclization/hydrolysis cascade reactions were reported.
Experimental

Materials
Trans-β-nitroolefins, benzotrifluoride, TiCl 3 were purchased from commercial Specific rotations were measured in a Perkin-Elmer 343 polarimeter at room temperature and λ = 589 nm. The purification of all compounds was carried out by column chromatography using (silica gel 200 -300).
Synthesis of β-Aryl-γ-Nitroalkanes 4 Vis Asymmetric Michael Addition
For the synthesis of the important intermediates β-aryl-γ-nitroalkanes 4, asymmetric Michael addition was studied. We initially examined two kinds of cinchona alkaloid-derived bifunctional thioureas 3a-b as potential organocatalysts for the asymmetric Michael addition of S, S'-diphenyldithiomalonate 2 to trans-β-nitroolefins 1 in benzotrifuoride at room temperature, leading to the expected γ-nitroalkanes derivative 4 in good yield and excellent stereoselectivity (Table 1) . Quinidine-derived thiourea 3b, pseudoenantiomer of 3a, effectively catalyzed the reaction and gave 4a, 4b and 4c with opposite absolute configuration in similar enantioselectivities (Table 1, After filtration, the products were furnished. 
Synthesis of (S)/(R)-β-Phenyl-γ-Lactam 5a
Considering that β-aryl-γ-nitroalkanes derivatives 4 are potential drug candidates, the transformation of adduct 4a to 5a was investigated as illustrated in Scheme 1. When adduct (S)-4a (96% ee) was treated with zinc/acetic acid and TiCl 3 , nitro group transformed into the amine and followed by intramolecular cyclization to produce the (S)-β-phenyl-γ-lactam 5a in good yield (90%) and only a few influence of enantioselectivity (91% ee) via subsequent reduction/ cyclization cascade reactions in a one-pot sequential protocol [10] . Under identical conditions, the adduct (R)-4a (98% ee) was transformed into (R)-β-phenyl-γ-lactam 5a in 90% yield and 89% ee (Scheme 1). 
Synthesis of (S)/(R)-Phenibut
Phenibut is a therapeutically useful agonist of GABA type-B receptors and is used as a neuropsychotropic drug [11] [12] . To get the enantiomerically pure Phenibut, a tandem hydrolysis-decarboxylation reaction of the β-phenyl-γ-lac- 
Conclusion
In conclusion, we have developed the first example of cinchona alkaloid-derived thioureas-catalyzed asymmetric Michael addition of S, S'-diphenyldithiomalo- 
